DK0630428T3 - Fremgangsmåde til fremstilling af taxanderivater - Google Patents

Fremgangsmåde til fremstilling af taxanderivater

Info

Publication number
DK0630428T3
DK0630428T3 DK93918756.3T DK93918756T DK0630428T3 DK 0630428 T3 DK0630428 T3 DK 0630428T3 DK 93918756 T DK93918756 T DK 93918756T DK 0630428 T3 DK0630428 T3 DK 0630428T3
Authority
DK
Denmark
Prior art keywords
radical
general formula
taxane derivatives
preparation
trichloro
Prior art date
Application number
DK93918756.3T
Other languages
Danish (da)
English (en)
Inventor
Dominique Deprez
Jean-Pierre Pulicani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of DK0630428T3 publication Critical patent/DK0630428T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00Electrolytic production of organic compounds
    • C25B3/20Processes
    • C25B3/25Reduction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042Electrodes formed of a single material
    • C25B11/043Carbon, e.g. diamond or graphene
    • CCHEMISTRY; METALLURGY
    • C25ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25BELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042Electrodes formed of a single material
    • C25B11/046Alloys

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK93918756.3T 1992-03-13 1993-03-11 Fremgangsmåde til fremstilling af taxanderivater DK0630428T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9203000A FR2688518B1 (fr) 1992-03-13 1992-03-13 Procede de preparation de derives du taxane.

Publications (1)

Publication Number Publication Date
DK0630428T3 true DK0630428T3 (da) 1995-12-27

Family

ID=9427641

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93918756.3T DK0630428T3 (da) 1992-03-13 1993-03-11 Fremgangsmåde til fremstilling af taxanderivater

Country Status (21)

Country Link
EP (1) EP0630428B1 (enrdf_load_html_response)
JP (1) JPH07504461A (enrdf_load_html_response)
KR (1) KR950700439A (enrdf_load_html_response)
AT (1) ATE130053T1 (enrdf_load_html_response)
AU (1) AU3756393A (enrdf_load_html_response)
CA (1) CA2117552A1 (enrdf_load_html_response)
CZ (1) CZ218694A3 (enrdf_load_html_response)
DE (1) DE69300766T2 (enrdf_load_html_response)
DK (1) DK0630428T3 (enrdf_load_html_response)
ES (1) ES2079982T3 (enrdf_load_html_response)
FI (1) FI944190A7 (enrdf_load_html_response)
FR (1) FR2688518B1 (enrdf_load_html_response)
GR (1) GR3018036T3 (enrdf_load_html_response)
HU (1) HUT68282A (enrdf_load_html_response)
MX (1) MX9301345A (enrdf_load_html_response)
NO (1) NO943371L (enrdf_load_html_response)
RU (1) RU94041682A (enrdf_load_html_response)
SK (1) SK108494A3 (enrdf_load_html_response)
TW (1) TW235961B (enrdf_load_html_response)
WO (1) WO1993018210A1 (enrdf_load_html_response)
ZA (1) ZA931800B (enrdf_load_html_response)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
ES2211879T3 (es) * 1993-03-22 2004-07-16 Florida State University Taxanos que no tienen un grupo oxo en c9 y composiciones farmaceuticas que las contienen.
US5760251A (en) * 1995-08-11 1998-06-02 Sepracor, Inc. Taxol process and compounds
US6103698A (en) * 1997-03-13 2000-08-15 Basf Aktiengesellschaft Dolastatin-15 derivatives in combination with taxanes
JP4338527B2 (ja) 2002-04-05 2009-10-07 サンタリス ファーマ アー/エス HIF−1α発現を調節するオリゴマー化合物
US7713738B2 (en) 2003-02-10 2010-05-11 Enzon Pharmaceuticals, Inc. Oligomeric compounds for the modulation of survivin expression
JP4642775B2 (ja) 2003-12-23 2011-03-02 サンタリス ファーマ アー/エス Bcl−2のモデュレーションのためのオリゴマー化合物
US9447138B2 (en) 2004-11-09 2016-09-20 Roche Innovation Center Copenhagen A/S Potent LNA oligonucleotides for the inhibition of HIF-1a expression
MX2007005557A (es) 2004-11-09 2008-02-15 Santaris Pharma As Oligonucleotidos lna y el tratamiento de cancer.
MX2007005558A (es) 2004-11-09 2008-01-31 Santaris Pharma As Oligonucleotidos de lna potentes para la inhibicion dela expresion de hif-1a.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60187689A (ja) * 1984-03-06 1985-09-25 Otsuka Chem Co Ltd 3−エキソメチレンセフアム誘導体の製造法
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
FR2664894A1 (fr) * 1990-07-19 1992-01-24 Rhone Poulenc Sante Nouveaux derives de streptogramines et leur preparation.

Also Published As

Publication number Publication date
KR950700439A (ko) 1995-01-16
MX9301345A (es) 1993-09-01
DE69300766D1 (de) 1995-12-14
WO1993018210A1 (fr) 1993-09-16
GR3018036T3 (en) 1996-02-29
HU9402614D0 (en) 1994-11-28
FI944190A0 (fi) 1994-09-12
JPH07504461A (ja) 1995-05-18
FR2688518B1 (fr) 1994-05-06
DE69300766T2 (de) 1996-04-18
NO943371D0 (no) 1994-09-12
EP0630428A1 (fr) 1994-12-28
AU3756393A (en) 1993-10-05
FI944190A7 (fi) 1994-09-12
ZA931800B (en) 1993-09-30
ES2079982T3 (es) 1996-01-16
ATE130053T1 (de) 1995-11-15
HUT68282A (en) 1995-04-03
SK108494A3 (en) 1995-02-08
TW235961B (enrdf_load_html_response) 1994-12-11
CA2117552A1 (fr) 1993-09-16
RU94041682A (ru) 1996-07-20
NO943371L (no) 1994-09-12
EP0630428B1 (fr) 1995-11-08
FR2688518A1 (fr) 1993-09-17
CZ218694A3 (en) 1995-02-15

Similar Documents

Publication Publication Date Title
DE69333064D1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
YU68792A (sh) Postupak za dobivanje derivata bakatina iii i 10-dezacetil-bakatina iii
FI951591A0 (fi) Menetelmä taksaanijohdannaisten valmistamiseksi
DK0687259T3 (da) Fremgangsmåde til fremstilling af taxoider
DK0630428T3 (da) Fremgangsmåde til fremstilling af taxanderivater
MX9707427A (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que los contienen.